rs1026024
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_007191.5(WIF1):c.930C>T(p.Cys310Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0107 in 1,613,390 control chromosomes in the GnomAD database, including 990 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.012 ( 115 hom., cov: 33)
Exomes 𝑓: 0.011 ( 875 hom. )
Consequence
WIF1
NM_007191.5 synonymous
NM_007191.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.432
Publications
5 publications found
Genes affected
WIF1 (HGNC:18081): (WNT inhibitory factor 1) The protein encoded by this gene functions to inhibit WNT proteins, which are extracellular signaling molecules that play a role in embryonic development. This protein contains a WNT inhibitory factor (WIF) domain and five epidermal growth factor (EGF)-like domains, and is thought to be involved in mesoderm segmentation. This gene functions as a tumor suppressor gene, and has been found to be epigenetically silenced in various cancers. [provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 12-65055206-G-A is Benign according to our data. Variant chr12-65055206-G-A is described in ClinVar as Benign. ClinVar VariationId is 1236341.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.432 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.166 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0123 AC: 1876AN: 152138Hom.: 116 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1876
AN:
152138
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0303 AC: 7592AN: 250564 AF XY: 0.0289 show subpopulations
GnomAD2 exomes
AF:
AC:
7592
AN:
250564
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0105 AC: 15357AN: 1461134Hom.: 875 Cov.: 30 AF XY: 0.0116 AC XY: 8429AN XY: 726818 show subpopulations
GnomAD4 exome
AF:
AC:
15357
AN:
1461134
Hom.:
Cov.:
30
AF XY:
AC XY:
8429
AN XY:
726818
show subpopulations
African (AFR)
AF:
AC:
51
AN:
33448
American (AMR)
AF:
AC:
2576
AN:
44582
Ashkenazi Jewish (ASJ)
AF:
AC:
44
AN:
26114
East Asian (EAS)
AF:
AC:
5870
AN:
39678
South Asian (SAS)
AF:
AC:
5178
AN:
86010
European-Finnish (FIN)
AF:
AC:
12
AN:
53408
Middle Eastern (MID)
AF:
AC:
15
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
351
AN:
1111766
Other (OTH)
AF:
AC:
1260
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
663
1325
1988
2650
3313
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
230
460
690
920
1150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0123 AC: 1869AN: 152256Hom.: 115 Cov.: 33 AF XY: 0.0146 AC XY: 1086AN XY: 74436 show subpopulations
GnomAD4 genome
AF:
AC:
1869
AN:
152256
Hom.:
Cov.:
33
AF XY:
AC XY:
1086
AN XY:
74436
show subpopulations
African (AFR)
AF:
AC:
118
AN:
41542
American (AMR)
AF:
AC:
416
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
4
AN:
3470
East Asian (EAS)
AF:
AC:
910
AN:
5186
South Asian (SAS)
AF:
AC:
358
AN:
4826
European-Finnish (FIN)
AF:
AC:
1
AN:
10596
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
29
AN:
68022
Other (OTH)
AF:
AC:
33
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
89
178
266
355
444
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
434
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 05, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.